[TECH NEWS] University of Guelph (Canada) researchers have found the location and effect of abnormal heart proteins that can cause cardiac failure, a discovery that points to potential new ways to treat the most costly health problem in the world. The study appears today in PLoS ONE, a peer-reviewed international journal published by the Public Library of Science. It is available… Read more »
[TECH NEWS] The tantalizing prospect of treating a range of brain diseases, such as Alzheimer’s and Parkinson’s, all with the same drug, has been raised by UK researchers. In a study, published in Nature, they prevented brain cells dying in mice with prion disease. It is hoped the same method for preventing brain cell death could apply in other diseases. The… Read more »
[TECH NEWS] Real-time, 3D microscopic tissue imaging could be a revolution for medical fields such as cancer diagnosis, minimally invasive surgery and ophthalmology. University of Illinois researchers have developed a technique to computationally correct for aberrations in optical tomography, bringing the future of medical imaging into focus. The computational technique could provide faster, less expensive and higher resolution tissue imaging to… Read more »
[TECH NEWS] Daily physical exercise may reduce the risk of Alzheimer’s disease, even in people over the age of 80, according to a study published in the April 18, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology. “The study showed that not only exercise but also activities such as cooking, washing the dishes and cleaning… Read more »
[TECH NEWS] A blood test that can predict whether a person is at high risk of suffering from a heart attack has been developed by researchers at Scripps Translational Science Institute, and published in the journal Science Translational Medicine. The test can provide the doctor and patient with this vital information up to two weeks before an acute myocardial infarction (heart attack)… Read more »
The March-April issue of Cryonics features an extensive treatment of protecting one’s cryonics arrangements against inflation through life insurance. Insurance agent and Alcor member Rudi Hoffman makes the case for “superfunding” your cryonics arrangements to keep pace with the rising costs of advanced medical procedures. The author explains the differences between the major forms of life insurance (term life, whole… Read more »
[FEATURED ARTICLE] Cryonics, March-April 2012 By Mike Perry Alzheimer’s disease (AD) is the most common form of dementia. There is no cure, it worsens as it progresses, and it is uniformly fatal, though typically requiring 7-14 years to run its course from what up to now have been the first detectable, identifiable symptoms. (Symptoms may show up earlier than this… Read more »
[FEATURED ARTICLE] Cryonics March-April 2012 By Rudi Hoffman Background on Cryonics Funding By now, most members and potential members reading these words are aware that Alcor is anticipating enacting an historic — and no doubt much discussed — new pricing model. This will almost certainly impact nearly everyone reading this article, even members of other cryonics organizations or those intending… Read more »
[TECH NEWS] Alzheimer’s disease (AD) is now the sixth leading cause of death among Americans, affecting nearly 1 in 8 people over the age of 65. There is currently no treatment that alters the course of this disease. However, an increasing amount of evidence suggests that changes in the way the body handles iron and other metals like copper and… Read more »
[TECH NEWS] Targeted therapeutic nanoparticles that accumulate in tumors while bypassing healthy cells have shown promising results in an ongoing clinical trial, according to a new paper. The nanoparticles feature a homing molecule that allows them to specifically attack cancer cells, and are the first such targeted particles to enter human clinical studies. Originally developed by researchers at MIT and… Read more »
